Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells

International Journal of Molecular Medicine

Volumn 35, Issue 3, 2015, Pages 684-692

  Zhao, X ^a   Liu, G ^a   Shen, H ^a   Gao, B ^a   Li, X ^a   Fu, J ^a   Zhou, Jie ^a   Ji, Qiuhe ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Autophagy related gene; Glucagon like peptide 1 receptor; High glucose; Liraglutide

Indexed keywords

BECLIN 1; CASPASE 3; CREATININE; EXENDIN (9 39); GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; LIRAGLUTIDE; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLP1R PROTEIN, HUMAN; GLP1R PROTEIN, RAT; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; LC3 PROTEIN, RAT; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BODY WEIGHT; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CELL VACUOLE; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG HALF LIFE; FOOD INTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY TUBULE CELL; LONG TERM EXPOSURE; MEMBRANE STRUCTURE; MTS ASSAY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; TISSUE STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; UREA NITROGEN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; CELL SURVIVAL; CYTOLOGY; DIABETIC NEPHROPATHY; DRUG EFFECTS; EPITHELIUM CELL; KIDNEY TUBULE; MALE; METABOLISM; PATHOLOGY; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GLUCOSE; HYPOGLYCEMIC AGENTS; KIDNEY TUBULES; LIRAGLUTIDE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; RATS; RECEPTORS, GLUCAGON;

EID: 84921710892     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.2052     Document Type: Article

References (43)

1. Chen L, Magliano DJ and Zimmet PZ: The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat Rev Endocrinol 8: 228-236, 2011.
2. de Zeeuw D, Parving HH and Henning RH: Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 17: 2100-2105, 2006.
3. Go AS, Chertow GM, Fan D, McCulloch CE and Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
4. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F and Fogarty DG: Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52: 691-697, 2009.
5. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
6. Brownlee M, Cerami A and Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988.
7. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K and King GL: Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100: 115-126, 1997.
8. Dunlop M: Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77: S3-S12, 2000.
9. Ziyadeh FN, Sharma K, Ericksen M and Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93: 536-542, 1994.
10. Singh DK, Winocour P and Farrington K: Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol 4: 216-226, 2008.
11. Miyata T and de Strihou Cv: Diabetic nephropathy: a disorder of oxygen metabolism? Nat Rev Nephrol 6: 83-95, 2010.
12. Giacco F and Brownlee M: Oxidative stress and diabetic complications. Circ Res 107: 1058-1070, 2010.
13. Kashihara N, Haruna Y, Kondeti VK and Kanwar YS: Oxidative stress in diabetic nephropathy. Curr Med Chem 17: 4256-4269, 2010.
14. Hakim FA and Pflueger A: Role of oxidative stress in diabetic kidney disease. Med Sci Monit 16: RA37-RA48, 2010.
15. Ha H, Hwang IA, Park JH and Lee HB: Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 82 (Suppl 1): S42-S45, 2008.
16. Wu J, Zhang R, Torreggiani M, et al: Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation. Am J Pathol 176: 2163-2176, 2010.
17. Qi W, Mu J, Luo ZF, et al: Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response. Metabolism 60: 594-603, 2011.
18. Cybulsky AV, Takano T, Papillon J, Kitzler TM and Bijian K: Endoplasmic reticulum stress in glomerular epithelial cell injury. Am J Physiol Renal Physiol 301: F496-F508, 2011.
19. Masini M, Bugliani M, Lupi R, et al: Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 52: 1083-1086, 2009.
20. Ebato C, Uchida T, Arakawa M, et al: Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab 8: 325-332, 2008.
21. Hartleben B, Gödel M, Meyer-Schwesinger C, et al: Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120: 1084-1096, 2010.
22. Kimura T, Takabatake Y, Takahashi A, et al: Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol 22: 902-913, 2011.
23. Jiang M, Liu K, Luo J and Dong Z: Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol 176: 1181-1192, 2010.
24. Kume S, Uzu T, Horiike K, et al: Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest 120: 1043-1055, 2010.
25. Ohsumi Y and Mizushima N: Two ubiquitin-like conjugation systems essential for autophagy. Semin Cell Dev Biol 15: 231-236, 2004.
26. Xie Z and Klionsky DJ: Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9: 1102-1109, 2007.
27. Baggio LL and Drucker DJ: Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157, 2007.
28. Farilla L, Hui H, Bertolotto C, et al: Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143: 4397-4408, 2002.
29. Nauck MA, Niedereichholz U, Ettler R, et al: Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 273: E981-E988, 1997.
30. Turton MD, O'Shea D, Gunn I, et al: A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72, 1996.
31. Bullock BP, Heller RS and Habener JF: Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137: 2968-2978, 1996.
32. Wajcberg E and Amarah A: Liraglutide in the management of type 2 diabetes. Drug Des Devel Ther 4: 279-290, 2010.
33. Hayes MR, Kanoski SE, Alhadeff AL and Grill HJ: Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats. Obesity (Silver Spring) 19: 1342-1349, 2011.
34. Sugimoto H, Shikata K, Hirata K, et al: Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 46: 2075-2081, 1997.
35. Mizushima N, Levine B, Cuervo AM and Klionsky DJ: Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075, 2008.
36. Martinet W and De Meyer GR: Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res 104: 304-317, 2009.
37. Zhang H, Kong X, Kang J, et al: Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol Sci 110: 376-388, 2009.
38. Kiyono K, Suzuki HI, Matsuyama H, et al: Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res 69: 8844-8852, 2009.
39. Kawakami T, Inagi R, Takano H, et al: Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. Nephrol Dial Transplant 24: 2665-2672, 2009.
40. Marsh BJ, Soden C, Alarcón C, et al: Regulated autophagy controls hormone content in secretory-deficient pancreatic endocrine beta-cells. Mol Endocrinol 21: 2255-2269, 2007.
41. Law BY, Wang M, Ma DL, et al: Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase pump, induces autophagy, endoplasmic reticulum stress, and apoptosis. Mol Cancer Ther 9: 718-730, 2010.
42. Zhu J, Wang KZ and Chu CT: After the banquet: mitochondrial biogenesis, mitophagy, and cell survival. Autophagy 9: 1663-1676, 2013.
43. Petersen M, Hofius D and Andersen SU: Signaling unmasked: Autophagy and catalase promote programmed cell death. Autophagy 10: 520-521, 2014.